Search results
Results from the WOW.Com Content Network
The process of introducing a consent decree begins with negotiation. [5] One of three things happens: a lawsuit is filed and the parties concerned reach an agreement prior to adjudication of the contested issues; a lawsuit is filed and actively contested, and the parties reach an agreement after the court has ruled on some issues; or the parties settle their dispute prior to the filing of a ...
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...
The Act was intended to increase competition and provide incentives to the entry of generic medications. [ 6 ] [ 7 ] The first ruling by the US Supreme Court in relation to reverse payment settlements came in 2013, in which the Court ruled that the " Federal Trade Commission can sue pharmaceutical companies for potential antitrust violations ...
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...
Civil damages under the False Claims Act were paid out to the federal government in the amount of $83.6 million, and damages paid out to the states totaled $106.4 million. Relator David Franklin was awarded one of the highest shares ever under the False Claims Act, 29.5% of the settlement, in recognition of his important role in exposing the ...
What is a consent decree? The 1994 Violent Crime Control and Law Enforcement Act gave the civil rights division of the Justice Department the power to investigate systemic police misconduct.
The U.S. Attorney's Office for the Southern District announced a consent decree in a ... The lawsuit accused Mark Ford and several businesses operated under his name of violating the Clean Water Act.
In 2004, Schering-Plough was accused of marketing gimmicks and payoffs to doctors for prescribing the company's pharmaceutical products. [31] Schering-Plough entered a consent decree with the FDA on March 6, 2002 due to manufacturing issues with its albuterol inhaler. It was ordered to pay $500 million US dollars to the US Treasury.